Biocryst Pharmaceuticals buy HC Wainwright

Summary

This prediction ended on 07.05.26 with a price of €7.45. The price of Biocryst Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.76%. HC_Wainwright has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. HC_Wainwright has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Biocryst Pharmaceuticals	-9.302%	-9.302%	-27.721%
iShares Core DAX®	-1.756%	1.667%	2.099%
iShares Nasdaq 100	2.324%	12.779%	38.808%
iShares Nikkei 225®	5.022%	13.300%	60.099%
iShares S&P 500	0.802%	6.198%	25.356%